 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 852877
Online Users : 408
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/6738
|
| Title: | The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan |
| Authors: | Pan, SC;Kung, HC;Kao, TM;Wu, H;Dong, SX;Hu, MH;Chou, AH;Chong, P;Hsieh, SM;Chang, SC |
| Contributors: | Division of Vaccine Research and Development |
| Abstract: | BACKGROUND:Avian H5N1 influenza has caused human infections globally and has a high mortality rate. Rapid production of effective vaccines is needed.METHODS:A phase 1, randomized, observer-blinded clinical trial was conducted to examine the safety and immunogenicity of an inactivated whole virion vaccine against the influenza A/H5N1 virus produced from the Madin-Darby canine kidney (MDCK) cell line. Participants were randomized to four groups and administered two intramuscular doses of vaccine containing 3μg hemagglutinin (HA), 3μg HA with 300μg aluminum phosphate (AlPO(4)), 6μg HA, and 6μg HA with 300μg AlPO(4), respectively, at two visits, 21 days apart. Serum hemagglutination inhibition (HAI) and neutralizing antibody levels were determined at baseline and on Days 21 and 42. RESULTS:Sixty healthy individuals were enrolled. The neutralization assay showed a significant immune response in the 6μg with ALPO(4) group on Day 42 compared to pre-vaccination levels (11.32±9.77 vs. 4.00±0, p=0.02). The adjuvant effect in neutralization assay was also significant on Day 42 in the 6μg group (4.52±1.94 without adjuvant vs. 11.32±9.77 with adjuvant, p=0.02). HAI assay also showed an aluminum adjuvant-induced increasing trend in HAI geometric mean titer on Day 42 in the 3μg and 6μg groups (6.02 versus 8.20, p=0.05 and 5.74 versus 8.21, p=0.14). The most frequent adverse event was local pain (20% to 60%). There were no vaccine-related severe adverse effects.CONCLUSION:MDCK cell line-derived H5N1 vaccine was well tolerated. It is necessary to investigate further the immunogenicity of higher antigen doses and the role of aluminum adjuvant in augmenting the effect of the vaccine. |
| Date: | 2013-12 |
| Relation: | Journal of Microbiology, Immunology and Infection. 2013 Dec;46(6):448-455. |
| Link to: | http://dx.doi.org/10.1016/j.jmii.2012.08.002 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1684-1182&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000329598800007 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84890121995 |
| Appears in Collections: | [莊再成] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| SDO2012100104.pdf | | 432Kb | Adobe PDF | 463 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
